Life Sciences

VSA to Acquire HopeAI, Expanding AI in Life Sciences

VSA has signed a letter of intent to acquire HopeAI, aiming to enhance its presence in AI-powered clinical development.

June 17, 2025

MedHub-AI and Terumo Partner to Introduce AI-Based FFR in Japan

MedHub-AI has announced a partnership with Terumo Corporation to distribute its AI-powered AutocathFFR software in Japan, enhancing coronary physiology assessment.

June 17, 2025

Precisio Biotix Secures Grant for AI-Driven Antimicrobial Discovery

Precisio Biotix Therapeutics has received a grant from the Gates Foundation to develop novel lysin antimicrobials targeting bacterial vaginosis, using their AI/ML-guided platform.

June 17, 2025

Lunit AI Supports Mass Screening During 2025 Hajj in Saudi Arabia

Lunit's AI-based chest X-ray analysis tool, Lunit INSIGHT CXR, was utilized by the Saudi Government and Seha Virtual Hospital for mass screening during the 2025 Hajj season, aiding in the detection of respiratory diseases among millions of pilgrims.

June 16, 2025

Genesis Therapeutics Appoints Aleksandra Faust as Chief AI Officer

Genesis Therapeutics has appointed Aleksandra Faust, Ph.D., as Chief AI Officer, bringing her extensive AI research expertise from Google DeepMind to the company.

June 13, 2025

Ellipsis Health Unveils AI Care Manager Sage with $45M Funding

Ellipsis Health has introduced Sage, an AI Care Manager, backed by $45 million from Salesforce, Khosla Ventures, and CVS Ventures, to enhance patient care management.

June 13, 2025

Deep Apple and Novo Nordisk Partner on Cardiometabolic Drug Discovery

Deep Apple Therapeutics has announced a collaboration with Novo Nordisk to develop oral therapeutics for cardiometabolic diseases, potentially earning up to $812 million.

June 13, 2025

Outcomes4Me Acquires Mika Health App to Enhance AI-Driven Cancer Care

Outcomes4Me has acquired the Mika Health app from Fosanis GmbH to expand its AI-driven cancer care platform globally, announced in a press release.

June 13, 2025

AllSci Secures Grant to Enhance AI Platform for Pharma and Biotech

AllSci has been awarded a grant from Montgomery County's Technology Innovation Fund to expand its AI platform for pharmaceutical and biotech research, as announced in a press release.

June 11, 2025

Novo Nordisk Utilizes Gefion AI Supercomputer for Drug Discovery

Novo Nordisk has partnered with DCAI to leverage the Gefion AI supercomputer for advancing drug discovery and healthcare innovation, as announced in a press release.

June 11, 2025

Lembas Unveils AI-Driven GLP-1 Solution for Weight Management

Lembas has emerged from stealth with a breakthrough in natural GLP-1 activation for weight management, announced in a press release. The company secured $3.6 million in funding to scale its AI-powered bioactive discovery platform.

June 11, 2025

Guy's and St Thomas' NHS Launches AI-Driven PATH Initiative

Guy's and St Thomas' NHS Foundation Trust has launched the PATH initiative in collaboration with General Catalyst, NVIDIA, Hippocratic AI, and Sword Health to transform healthcare delivery using AI.

June 11, 2025

GLOBO KAI AI Interpreter Expands to 3,000 Healthcare Sites

GLOBO Language Solutions has announced the rollout of its AI interpreter, GLOBO KAI, to 3,000 healthcare providers across the U.S., enhancing communication for limited English proficiency patients.

June 11, 2025

Evogene and Google Cloud Develop AI Model for Molecule Design

Evogene has completed its generative AI foundation model for small molecule design in collaboration with Google Cloud, enhancing capabilities in pharma and agriculture.

June 10, 2025

Southwest General Partners with Notable for AI-Driven Patient Access

Southwest General Health Center has partnered with Notable to use AI for automating patient registration and care gap outreach, enhancing patient access and reducing staff workload.

June 10, 2025

Echosens and Boehringer Ingelheim Expand Partnership for MASH Diagnosis

Echosens and Boehringer Ingelheim have expanded their collaboration to enhance the diagnosis and care of metabolic dysfunction-associated steatohepatitis (MASH), focusing on early detection and non-invasive technologies.

June 10, 2025

Phare Bio Joins Google.org Accelerator for AI-Driven Antibiotic Discovery

Phare Bio has been selected to participate in the Google.org Accelerator, receiving funding and technical support to advance its AI-powered antibiotic discovery platform.

June 09, 2025

Axio BioPharma and Likarda Partner to Enhance Biologic Drug Development

Axio BioPharma and Likarda have announced a strategic partnership to integrate AI-powered protein manufacturing with advanced drug delivery technologies, aiming to accelerate biologic drug development.

June 09, 2025

Planet Green's AI Initiative Targets Youth Mental Health in Canada

Planet Green Holdings Corp. has announced a new AI-driven initiative to support early mental health intervention for Canadian youth, focusing on anxiety and depression.

June 09, 2025

CorroHealth Invests in SANTECHTURE to Enhance AI in Revenue Cycle Management

CorroHealth has made a strategic investment in SANTECHTURE, integrating its AI capabilities into SANTECHTURE's revenue cycle management products across the GCC region.

June 09, 2025